Dose-escalation Safety and Immunogenicity Study to Compare MTBVAC to BCG in Newborns With a Safety Arm in Adults
Clinical trial NCT02729571 · COMPLETED
Trial details
- NCT number
- NCT02729571
- Sponsor
- Biofabri, S.L
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-01
- Primary completion
- 2016-09-01
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.